Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
351,378
-
Share change
-
-175,997
-
Total reported value
-
$3,668,412
-
Price per share
-
$10.44
-
Number of holders
-
5
-
Value change
-
-$1,833,726
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q4 2023
As of 31 Dec 2023,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
351,378 shares.
The largest 10 holders included
BlackRock Inc., Ion Asset Management Ltd., Lingotto Investment Management LLP, Phoenix Holdings Ltd., Clal Insurance Enterprises Holdings Ltd, Migdal Insurance & Financial Holdings Ltd., Harel Insurance Investments & Financial Services Ltd., MENORA MIVTACHIM HOLDINGS LTD., Slate Path Capital LP, and Rubric Capital Management LP.
This page lists
439
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.